Cargando…
Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors
We describe a potential role for thymidine kinase-1, a general marker of cellular proliferation, to act as a prognostic biomarker in patients receiving CDK4/6 inhibitors for advanced hormone receptor-positive, HER2-negative breast cancer, with early data suggesting that it may also provide early ind...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374612/ https://www.ncbi.nlm.nih.gov/pubmed/32382111 http://dx.doi.org/10.1038/s41416-020-0858-y |